# Daiichi Sankyo Co., Ltd. Odawara Plant, Odawara, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/daiichi-sankyo-co-ltd-odawara-plant/83cd6ae3-96fe-46bb-85a7-2aee947e573b

> Inspection records and compliance data for Daiichi Sankyo Co., Ltd. Odawara Plant in Odawara. 3 FDA inspections on record, 1 Form 483, last inspected January 25, 2019.

---

## Details

- Name: Daiichi Sankyo Co., Ltd. Odawara Plant
- FEI Number: 3003279188
- Address Line 1: 477, Takata
- City: Odawara
- Country Name: Japan
- Address: 477, Takata, Odawara, Japan
- Country: Japan

## Related Documents

- [483 - Daiichi Sankyo Co., Ltd. Odawara Plant - 2019-01-25](https://www.keypedia.com/records/483/daiichi-sankyo-co-ltd-odawara-plant/aeedd5d2-72f2-4896-a258-2bbd6991fadf) — source: FDA, date: January 25, 2019
- [FDA Inspection 1081871 - Daiichi Sankyo Co., Ltd. Odawara Plant - 2019-01-25](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-co-ltd-odawara-plant/59630dec-a3a1-4c89-a348-2502b37755dc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2019
- FDA Inspection 971682 - Daiichi Sankyo Co., Ltd. Odawara Plant - 2016-04-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2016
- FDA Inspection 891670 - Daiichi Sankyo Co., Ltd. Odawara Plant - 2014-06-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2014

## Related Companies

- [Nippon Shikizai, Inc.](https://www.keypedia.com/companies/nippon-shikizai-inc/3c12bd96-80ba-4b34-8492-72de16d6e6f3)
- [Erode Cancer Centre](https://www.keypedia.com/companies/erode-cancer-centre/8d952bcb-5a81-4637-9f8f-55b3c4c600d6)
- [StageBio](https://www.keypedia.com/companies/stagebio/839d1a55-7810-466e-b202-efdae8782e4f)
- [Jason L. Aldred M.D.](https://www.keypedia.com/companies/jason-l-aldred-md/3f29a4ae-79ed-4279-b6d4-359863793b04)
- [Contract Pharmaceutical Services of Australia Pty Ltd](https://www.keypedia.com/companies/contract-pharmaceutical-services-of-australia-pty-ltd/7bfec6e4-38bf-4d91-8089-8a67f1f2d1e6)
- [Lumene Oy](https://www.keypedia.com/companies/lumene-oy/55dea55e-07bb-4096-82cd-5b848ce2a9f7)
- [Mario Campone](https://www.keypedia.com/companies/mario-campone/989af96d-907d-4f05-b911-f3f557ec17ef)
- [Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/lijiang-yinghua-biochemical-and-pharmaceutical-co-ltd/47ca4d69-d8d4-4f42-b93a-e2cdb161a872)
- [Syed Ali, M.D.](https://www.keypedia.com/companies/syed-ali-md/2a0ed90c-3627-4c10-a8ed-2eb544bf55d7)
- [Jennifer L. Miller, M.D.](https://www.keypedia.com/companies/jennifer-l-miller-md/69c691cc-d811-4c3e-81dd-146a581647dd)

## Related Officers

- [Pharmaceutical Program Expert](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)
